<DOC>
	<DOCNO>NCT02538432</DOCNO>
	<brief_summary>This phase II trial ( RQ-07 ) advance solid tumor prostate , breast non-small cell lung cancer .</brief_summary>
	<brief_title>Phase II Trial EP4 Receptor Antagonist , AAT-007 ( RQ-07 ; CJ-023,423 ) Advanced Solid Tumors</brief_title>
	<detailed_description>This phase II trial ( RQ-07 ) advance solid tumor advance prostate , breast lung cancer . The purpose trial determine whether administration study drug RQ-07 decrease circulate tumor cell advanced prostate , breast lung cancer . Additionally , study evaluate whether study drug may improve outcome advanced prostate , breast lung cancer either combine gemcitabine , standard chemotherapy drug . The combination gemcitabine investigate disease worsen study drug RQ-07 patient prostate lung cancer .</detailed_description>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>1 . Histologically cytologically confirm breast , prostate nonsmall cell lung cancer A tissue block , 10 unstained slide fresh tissue biopsy require . 2 . At least 2 week elapse since last treatment patient recover previous significant toxicity ( i.e . grade 1 less ) . 3 . ECOG Performance Status &lt; 2 . 4 . Patient least 18 year age old . 5 . Adequate hematological function define protocol , section 4.1.5 . 6 . Patients must serum creatinine within normal limit , estimate measure creatinine clearance &gt; 35 mg/ml/min . 7 . Normal serum electrolyte ( &gt; grade 2 abnormality ) , magnesium phosphorus day therapy . Correction abnormality permit . Adequate hepatic function per institutional standard ( see exclusion ) . 8 . All patient must inform investigational nature study must sign give write informed consent . 9 . Serum calcium , magnesium potassium must within normal limit . Supplementation achieve normal value permit . 10 . Patients potentially fertile sexually active must willing utilize effective birth control . 11 . Patients CNS metastasis are/were symptomatic must complete therapy ( surgery , gamma knife , XRT ) neurologically stable . 12 . Patients must &gt; = 4 circulate tumor cell 1 . Patients must serious infection serious underlie medical condition would impair ability patient receive protocol treatment . 2 . Current uncontrolled cardiac disease 3 . Acute bacterial fungal infection require intravenous antibiotic time registration 4 . Chronic Obstructive Pulmonary Disease exacerbation respiratory illness require hospitalization preclude study therapy within 4 week registration . 5 . Patients acquire Immune Deficiency Syndrome ( AIDS ) base upon current CDC definition patient know HIV positive 6 . Pregnancy woman childbearing potential men sexually active willing/able use medically acceptable form contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Disease Progression</keyword>
	<keyword>Non-Responsive Disease</keyword>
	<keyword>Advanced Disease</keyword>
</DOC>